Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 5 (2008), Issue 3 (March)

1. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
   Br J Pharmacol, 153(5): 1072-84. [Abstract] [Full-text]
2. Reflectance changes in clotting native blood: evidence of a red cell process.
   Pathophysiol Haemost Thromb, 36(1): 23-31. [Abstract] [Full-text]
3. Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors.
   Bioorg Med Chem, 16(5): 2183-99. [Abstract] [Full-text]
4. Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam.
   J Appl Toxicol. [Abstract] [Full-text]
5. Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.
   Eur J Clin Pharmacol, 64(5): 511-9. [Abstract] [Full-text]
6. Impact of prescriber nonresponse on patient representativeness.
   Epidemiology, 19(2): 186-90. [Abstract] [Full-text]
7. Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.
   Oncology, 73(1): 21-5. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.